1. Home
  2. CTSO vs BEDU Comparison

CTSO vs BEDU Comparison

Compare CTSO & BEDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTSO
  • BEDU
  • Stock Information
  • Founded
  • CTSO 1997
  • BEDU 1994
  • Country
  • CTSO United States
  • BEDU China
  • Employees
  • CTSO N/A
  • BEDU N/A
  • Industry
  • CTSO Medical/Dental Instruments
  • BEDU Other Consumer Services
  • Sector
  • CTSO Health Care
  • BEDU Real Estate
  • Exchange
  • CTSO Nasdaq
  • BEDU Nasdaq
  • Market Cap
  • CTSO 57.2M
  • BEDU 58.7M
  • IPO Year
  • CTSO N/A
  • BEDU 2017
  • Fundamental
  • Price
  • CTSO $0.98
  • BEDU $1.95
  • Analyst Decision
  • CTSO Strong Buy
  • BEDU
  • Analyst Count
  • CTSO 3
  • BEDU 0
  • Target Price
  • CTSO $4.67
  • BEDU N/A
  • AVG Volume (30 Days)
  • CTSO 147.2K
  • BEDU 2.0K
  • Earning Date
  • CTSO 11-07-2024
  • BEDU 11-25-2024
  • Dividend Yield
  • CTSO N/A
  • BEDU N/A
  • EPS Growth
  • CTSO N/A
  • BEDU N/A
  • EPS
  • CTSO N/A
  • BEDU N/A
  • Revenue
  • CTSO $37,739,531.00
  • BEDU $304,874,554.00
  • Revenue This Year
  • CTSO $13.09
  • BEDU N/A
  • Revenue Next Year
  • CTSO $15.68
  • BEDU N/A
  • P/E Ratio
  • CTSO N/A
  • BEDU N/A
  • Revenue Growth
  • CTSO 1.80
  • BEDU 12.26
  • 52 Week Low
  • CTSO $0.70
  • BEDU $1.05
  • 52 Week High
  • CTSO $2.15
  • BEDU $3.23
  • Technical
  • Relative Strength Index (RSI)
  • CTSO 44.01
  • BEDU 49.37
  • Support Level
  • CTSO $0.71
  • BEDU $1.83
  • Resistance Level
  • CTSO $0.99
  • BEDU $2.00
  • Average True Range (ATR)
  • CTSO 0.09
  • BEDU 0.08
  • MACD
  • CTSO 0.00
  • BEDU -0.00
  • Stochastic Oscillator
  • CTSO 59.97
  • BEDU 40.11

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About BEDU Bright Scholar Education Holdings Limited each representing four

Bright Scholar Education Holdings Ltd operates as an education service provider. The company offers overseas schools, complementary education services, and domestic kindergartens and K12 operation services. The group's overseas K12 education has several K12 schools, art colleges, language training institutions, and summer schools around the world. The complimentary education services segment of the company predominantly includes camp programs, after-school programs, through a network of learning centers in China, as well as international education consulting services. Geographically, the company operates in China which is the key revenue generating market, Canada, United States, and United Kingdom.

Share on Social Networks: